Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective, Real-life Observational Evaluation of the Effectiveness and Cost-effectiveness of Extra-fine Hydrofluoroalkane (HFA) Beclometasone (BDP) Compared With Fluticasone Propionate (FP) in the Management of Asthma in a Representative Population in the United States (US)

NCT01287351 is registered in ClinicalTrials.gov with Research in Real-Life Ltd as lead sponsor.

NCT NCT01287351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01287351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective, Real-life Observational Evaluation of the Effectiveness and Cost-effectiveness of Extra-fine Hydrofluoroalkane (HFA) Beclometasone (BDP) Compared With Fluticasone Propionate (FP) in the Management of Asthma in a Representative Population in the United States (US)
Lead sponsor
Research in Real-Life Ltd
Phase
Observational
Overall status
Completed
Start date
January 31, 2004
Completion date
October 31, 2010
Enrollment
82,903 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma